ClinicalTrials.gg
CompletedNCT04384874Updated Apr 22, 2024

A Novel Multi-factorial Criteria-based Rehabilitation Program for Chronic Mid-portion Achilles Tendinopathy

An interventional study of Exercise therapy in Achilles Tendinopathy, sponsored by Sports Surgery Clinic, Santry, Dublin. Completed at 1 site in Ireland. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-22.

Sponsored by Sports Surgery Clinic, Santry, Dublin · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Sixty physically active patients (aged 18-45) with chronic mid-portion Achilles tendinopathy will be recruited to take part in the study. The patients will be diagnosed by a sports medicine doctor and an MRI scan and will be experiencing palpable Achilles pain at the time of inclusion. The patients will be randomized into either a group performing the Silbernagel combined concentric-eccentric program, or a group performing a novel multi-phase program with specific outcome measures. The study will assess the patients calf strength, reactive strength and running biomechanics at baseline, week's 6 and 12 of a rehabilitation program and be available for a 6 month, 12 month and 2 year follow-up interview. The VISA-A questionnaire will be the primary outcome measure and will be completed at each testing and follow-up session.

Read the detailed description

Achilles tendinopathy is an overuse injury commonly seen in sports and physical activities that involve running, jumping and hopping. Patients with Achilles tendinopathy experience pain, morning stiffness and reduced ability to exercise. This condition can last for several years in some cases.

Exercise therapy in the form of resistance training has been demonstrated to be the most effective rehabilitation tool to reduce pain and increase function in patients with Achilles tendinopathy. Patients often experience clinical improvements before any meaningful structural changes on MRI or ultrasound imaging are observed. Returning athletes back to competitive sport requires a progressive loading program to enable them to tolerate high stretch-shortening cycle loads appropriate to the demands of their sport.

The SSC6 rehabilitation program is a six-stage pathway with a focus on strength development of the local muscle-tendon unit and the kinetic chain, the development of power and kinetic strength, running biomechanics and running load modification. The progression through each phase is guided by objective outcome criteria based on pain and function, strength and performance tests and achieving individualised resistance load targets. The strength and power exercises are performed at high intensity three days per week with 48 hours recovery. The Silbernagel program is a four-phase involves a daily exercise program of lower intensity with progression through each phase guided by symptoms and function.

This study will compare the effectiveness of a comprehensive Achilles tendinopathy rehabilitation program with progression criteria with a common Achilles tendinopathy rehabilitation program. Sixty recreationally-active subjects aged between 18-45 years who meet the inclusion criteria, will be recruited to partake in this study. The subjects will be randomly assigned to one of two groups where they will undergo a multi-phase rehabilitation program. Data will be collected at baseline, 6 weeks and 12 weeks, to monitor pain and functional response, biomechanical and structural changes. At 6, 12 and 24 months following the commencement of the rehabilitation program, patients will be required to complete a follow-up questionnaire to monitor progress and any re-injury incidence that may have occurred.

The following testing protocols will be performed:

  1. VISA-A Questionnaire The VISA-A questionnaire has been shown to be a valid, reliable and easy to use outcome measure tool for intervention studies on Achilles tendinopathy. It consists of eight questions regarding pain and function during both daily living and sporting activities. The overall score is between 0-100 where higher scores represent reduced pain and improved function. An improvement of 21 points between 2 and 12 weeks of a rehabilitation program have been typically observed. The difference in VISA-A score between both training protocols from baseline testing to the outcome testing at 6 weeks, 12 weeks, 6 and 12 months; will formulate the primary outcome measure for this study.
  2. Ankle isokinetic testing Achilles tendinopathy has been associated with reduced plantar flexor strength. Isokinetic testing is commonly used to measure plantarflexor peak torque. The subjects will perform 2 isokinetic tests. In the first test the subjects will lie in a prone position in an isokinetic dynamometer with full knee extension and the foot securely strapped to a pedal a neutral ankle position (tibia perpendicular to the sole of the foot). The centre of rotation of the ankle axis will be aligned with the dynamometer. Subjects will be asked to perform a warm-up involving 5 sub maximal concentric plantarflexion and dorsiflexion contractions between 60-100% of their self-perceived MVC. The subjects will then be required to produce a maximal plantarflexion force 5 repetitions for 2 sets with a 1 minute rest between sets. In the second test the subjects will lie in supine position with the knee flexed to 80º in order to specifically test the peak torque of the soleus. The same warm-up protocol and sets and repetitions as the previous test will apply. Both tests will use a speed of 60º per second and operate through an ankle range of between 30º plantarflexion and 20º dorsiflexion.
  3. Running biomechanics Altered running biomechanics and muscle recruitment strategies have been highlighted in runners with Achilles tendinopathy. The subjects will be asked to run on the treadmill at a self-selected sub maximal speed. Using 3D motion analysis (Run 3D, Oxford, United Kingdom), a number of biomechanical variables will be measured. These include: vertical and leg stiffness, contact time, flight time, stride length, stride frequency and joint angular displacements from initial contact to mid stance phase.
  4. Hop testing Achilles tendon material properties contribute to stretch shortening cycle performance during hopping tasks. Reduced tendon mechanical properties, plantar flexor muscle rate of force development and deficits on a single leg horizontal hop have previously been observed in patients with Achilles tendinopathy. Jump height, ground contact time and reactive strength index (RSI) will be measured using a double and single leg drop jump. Vertical, leg and ankle joint stiffness will be calculated using a novel single leg hurdle hop test. A pilot study has previously been carried out on 10 healthy subjects prior to the commencement of the Achilles RCT study. Good to excellent reliability was found for of vertical stiffness, contact time, ground reaction force, hop distance and rebound distance and 3 trials were sufficient to obtain a true measure of performance across most variables.
  5. Subjective questionnaire After the completion of the rehabilitation program patients will be ask to provide feedback on the prescribed program and will complete a training diary where compliance and adherence to the program will be monitored.
02

Conditions studied

  • Achilles Tendinopathy

Browse trials for

03

In context

Tendinopathy

397 studies on the registry are indexed under Tendinopathy; 77 are open to participants now.

This study's enrollment of 29 is below the median of 48 across 332 interventional studies indexed under Tendinopathy.

Browse Tendinopathy studies →

Lead sponsor

Sports Surgery Clinic, Santry, Dublin is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with mid-portion Achilles Tendinopathy by a sports medicine physician
  • Have experienced symptoms for more than 3 months and less than 3 years
  • Aged between 18-45 years,
  • Regularly perform running-based exercise more than twice per week

Exclusion criteria

Exclusion Criteria:

  • Have a co-existing lower limb injury.
  • Have had another running-related injury in the previous 12 months.
  • Have had an Achilles injection in the past 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
29 participants (actual)

Study arms

  • Active comparator
    Silbernagel combined concentric-eccentric program

    A graduated rehabilitation program using exercises with concentric and eccentric contractions and progressing to plyometric training. The exercises are performed daily with progression guided by pain symptoms. There is no specificity in prescribed exercise loading.

    Other: Exercise therapy

  • Experimental
    SSC6

    A multi-stage rehabilitation program with focus on strength and reactive strength targets, as well as running gait re-training. These exercises will be initially carried out 3 days per week for the first 6 weeks with specific load targets prescribed.

    Other: Exercise therapy

Interventions

  • OtherExercise therapy

    A 12 week multi-stage exercise rehabilitation program

06

What researchers measure

Primary outcomes

  1. Change in VISA-A Questionnaire score

    This is a measure of pain and lower limb function associated with Achilles tendinopathy and a primary outcome measure will be the change in VISA-A questionnaire at various time points during the 12 week intervention and in the long-term follow-ups. A change of 20 points is typically observed after a rehabilitation program, while a 10 point increase is accepted as being clinically meaningful.

    Time frame: This will be assessed at week 6 and 12, as well as 6, 12 and 24 month follow-ups

Secondary outcomes

  1. Plantar flexor strength

    Measured using isokinetic dynamometry to determine plantar flexor peak torque relative to bodyweight (Nm/kg) with 2 test protocols.

    Time frame: This will be carried out at week 0, 6 and 12

  2. Running biomechanics

    Using 3D motion analysis (Run 3D, Oxford, United Kingdom) a number of kinematic and spatiotemporal variables will be measured: contact time, flight time, stride length, stride frequency and joint angular displacements from initial contact to mid stance phase. Spring mass model characteristics and especially lower limb stiffness will be calculated using a validated equitation based on running speed, contact time, body mass and leg length dimensions. After a brief warm-up, the subject will be asked to run at a speed they feel that they could sustain for a 30 minute steady effort and data will be captured for 30 seconds. The running speed selected by the subject at baseline testing will be repeated for the two subsequent testing sessions.

    Time frame: This will be carried out at week 0, 6 and 12

  3. Lower limb reactive strength

    Patients will be asked to perform a double and single leg vertical drop jump and a single leg horizontal rebound task to assess lower limb biomechanics and reactive strength qualities.

    Time frame: This will be carried out at week 6 and 12

07

Study locations

1 site
  • Sports Surgery Clinic
    Dublin, Leinster, Ireland
08

References and documents

Publications

  • Griffin C, Daniels K, Hill C, Franklyn-Miller A, Morin JB. A criteria-based rehabilitation program for chronic mid-portion Achilles tendinopathy: study protocol for a randomised controlled trial. BMC Musculoskelet Disord. 2021 Aug 14;22(1):695. doi: 10.1186/s12891-021-04553-6. PubMed 34391384 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2020 to primary completion in Jan 2023, 36 months.

Of 174 non-industry interventional studies with no phase under Tendinopathy, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's 36 months is above that.

Counting every sponsor, half of 183 studies reached it within 20 months; a quarter within 7 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 23, 2020
First posted
May 12, 2020
StartActual
Jan 29, 2020
Primary completionActual
Jan 30, 2023
CompletionActual
May 31, 2023
Last update
Apr 22, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04384874
Lead sponsor
Sports Surgery Clinic, Santry, Dublin
Responsible party
Dr Neil Welch ASCC (Head of lab services and research, Sports Surgery Clinic, Santry, Dublin) — Principal investigator
First posted
May 12, 2020
Start date
Jan 29, 2020
Primary completion
Jan 30, 2023
Completion
May 31, 2023
Last update
Apr 22, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion